Intradermal administration of measles vaccines. 1994

J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
Faculty of Medical Sciences, University of São Paulo, Brazil.

The aim of the study reported here was to determine if bifurcated needles or multiple puncture cylinders would prove suitable for administration of measles vaccines. Children 9 to 11 months old in São Paulo, Brazil, were assigned to receive either Biken-Cam 70 (5,000 TCID50/0.5 ml) or Edmonston-Zagreb (7,000 TCID50/0.5 ml) measles vaccines intradermally with a bifurcated needle or a multiple puncture cylinder. These devices are usually used to administer smallpox or BCG vaccine. The volume of vaccine inoculated was approximately 0.003 ml. Measles IgG antibodies were measured by enzyme-linked immunosorbent assay (ELISA) at the time of vaccination and 8 weeks later. The study participants were examined 14 days after inoculation for possible adverse reactions. Overall, the children's average age was 9.5 +/- 0.66 months at vaccination. None of the 45 recipients of Biken-Cam vaccine responded serologically. The 49 Edmonston-Zagreb vaccine recipients immunized with the multiple puncture cylinder had a somewhat higher serologic response rate (35%) and mean concentration of measles antibodies (323 mIU/ml) than those 51 who received the same vaccine administered with the bifurcated needle (26% and 291 mIU/ml, respectively). The rates of reported symptoms after vaccination did not differ significantly among the groups. Overall, the low serologic response rates following intradermal immunization with for devices tested in this study indicate that this route of administration is not suitable for routine administration of standard-titer vaccines.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
April 1998, Reviews in medical virology,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
August 1977, Annals of allergy,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
April 1968, Revista clinica espanola,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
January 1965, Nursing times,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
January 2004, Pharmaceutical research,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
June 1990, Pediatric clinics of North America,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
March 1966, The Nova Scotia medical bulletin,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
March 1967, Canadian Medical Association journal,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
July 1965, The Medical letter on drugs and therapeutics,
J C de Moraes, and M E León, and V A Souza, and C Pannuti, and C Travisanello, and N A Halsey, and C A de Quadros
May 1964, The Medical journal of Australia,
Copied contents to your clipboard!